跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
心臟血管外科
醫學系
外科學科
郵寄地址
在地圖上顯示
概覽
指紋
網路
專家檔案
(6)
專案
(22)
研究成果
(127)
指紋
查看啟用 心臟血管外科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Abdominal Aortic Aneurysm
68%
Acute Kidney Injury
20%
Adenocarcinoma
23%
Alternative Complement Pathway C3 C5 Convertase
18%
Angiogenesis
35%
Aortic Aneurysm Endovascular Graft
20%
Aortic Dissection
100%
Aortic Valve
18%
Apoplexy
20%
Arrhythmogenesis
83%
Arteriovenous Fistula
32%
Atherogenesis
20%
Atherosclerosis
20%
Biopsy
32%
Cardiac Muscle Cell
29%
Cardiogenic Shock
32%
Cardiovascular Disease
25%
Cardiovascular System
36%
Cell Function
33%
Chaperonin 60
18%
Chronic Obstructive Pulmonary Disease
32%
Clinical Stage
32%
Cohort Analysis
54%
Computed Tomography Angiography
25%
Computer Assisted Tomography
71%
Coronary Artery
66%
Coronary Artery Bypass Graft
48%
Coronary Artery Bypass Surgery
24%
Coronary Computed Tomography Angiography
20%
Diabetes
26%
Diagnosis
20%
Dipeptidyl Peptidase IV
18%
Disease
28%
Endothelial Cell
44%
Endothelial Progenitor Cell
64%
Endovascular Aneurysm Repair
87%
Extracorporeal Membrane Oxygenation
49%
Framingham Risk Score
27%
Geriatrics
18%
Graft Infection
22%
Hazard Ratio
55%
Health Care Cost
35%
Heart Atrium Arrhythmia
18%
Heart Atrium Remodeling
34%
Heart Surgery
18%
Heart Ventricle Arrhythmia
32%
Hemodialysis
22%
Histone Deacetylase
32%
Hypoxia
23%
Iliac Artery Aneurysm
32%
Immunoglobulin Enhancer Binding Protein
21%
In Vitro
59%
Influenza Vaccination
32%
Injury
21%
Internal Iliac Artery
18%
Interstitial Cell
22%
Ischemia
28%
Ischemic Heart Disease
18%
Isotopes of Calcium
37%
Limb Ischemia
24%
Lipopolysaccharide
19%
Lung Adenocarcinoma
38%
Macrophage
18%
Maturation
20%
Mesenchymal Stem Cell
18%
Meta-Analysis
32%
microRNA
32%
Monocyte
34%
Mortality Rate
26%
Myocardial Infarction
29%
Neoplasm
19%
Nitric Oxide
38%
Nitric Oxide Synthase
20%
Non Small Cell Lung Cancer
32%
Nuclear Factor
18%
Oxidized Low Density Lipoprotein
27%
P. Gingivalis
23%
Percutaneous Coronary Intervention
22%
Pericarditis
21%
Politef
48%
Porphyromonas gingivalis
48%
Programmed Cell Death
37%
Pseudoephedrine Plus Triprolidine
32%
Pulmonary Valve Insufficiency
21%
Pulmonary Valve Replacement
19%
Randomized Controlled Trial
18%
Revascularization
20%
RNA Sequencing
18%
Secretion (Process)
20%
Short Chain Fatty Acid
19%
Stent-Graft
48%
Stromal Cell
32%
Surgeon
25%
Surgery
34%
Survival Rate
26%
Systematic Review
18%
Tetralogy of Fallot
20%
Toll Like Receptor 4
35%
Trimethylamine
19%
Ursolic Acid
32%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Aortic Aneurysm
48%
Aldosterone
16%
Allograft Inflammatory Factor 1
16%
Androgen Receptor Antagonist
16%
Angiotensin
16%
Angiotensin II
21%
Antiinfective Agent
34%
Aortic Dissection
48%
Arrhythmogenesis
67%
Arteriovenous Fistula
16%
Atherogenesis
44%
Atherosclerosis
23%
Atrial Fibrillation
16%
Biopolymer
16%
Carcinogenicity
16%
Cardiovascular Disease
28%
Cell Adhesion Molecule
27%
Chaperonin 60
32%
Chitosan
32%
Chlamydia Pneumoniae
48%
Chondroitin Sulfate
16%
Chronic Obstructive Lung Disease
36%
Cohort Study
78%
Comorbidity
23%
Coronary Artery Disease
21%
Cyclic AMP Responsive Element Binding Protein
16%
Diabetes Mellitus
16%
Dipeptidyl Peptidase IV
20%
Dipeptidyl Peptidase IV Inhibitor
16%
Disease
41%
Dysbiosis
16%
Endothelial Nitric Oxide Synthase
27%
Flutamide
16%
Fragility Fracture
16%
Fructose
16%
Fucoidan
22%
Galectin 3
16%
Graphene Oxide
30%
Heart Atrium Arrhythmia
18%
Heart Atrium Remodeling
34%
Heart Infarction
28%
Heart Ventricle Arrhythmia
32%
Heat Stroke
32%
Hematoma
16%
High Density Lipoprotein
16%
Histone Deacetylase
32%
HMG-CoA
16%
Honokiol
16%
Hydrogen Sulfide
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
16%
Immunoglobulin Enhancer Binding Protein
21%
Inflammation
73%
Ischemia
35%
Leporidae
16%
Limb Ischemia
21%
Long Term Survival
21%
Melatonin
16%
Metal Nanoparticle
16%
Metal Oxide
16%
Mevinolin
16%
Mitogen Activated Protein Kinase 3
24%
Mortality Rate
16%
Mouse
82%
Nanocarrier
16%
Nanohybrid
18%
Nanomaterial
16%
Nanoparticle
36%
Neovascularization (Pathology)
81%
Nickel
16%
Nitric Oxide
57%
Nitric Oxide Synthase
16%
Oxidized Low Density Lipoprotein
50%
Oxidized Low Density Lipoprotein Receptor 1
22%
Oxidoreductase
18%
Phosphotransferase
25%
Polyglutamic Acid
16%
Polystyrenesulfonic Acid
16%
Porphyromonas gingivalis
32%
Protein Kinase C
16%
Prothrombin
16%
Quercetin
16%
Randomized Controlled Trial
20%
Reactive Oxygen Metabolite
23%
Receptor
16%
Red Yeast Rice
16%
Renin
16%
Short Chain Fatty Acid
18%
Stainless Steel
20%
Stent-Graft
16%
Synthetase
16%
Thrombomodulin
16%
Toll Like Receptor 4
32%
Tolvaptan
16%
Transcription Factor RUNX2
20%
Trimethylamine
18%
Tumor Growth
16%
Ursolic Acid
32%
Vascular Remodeling
19%
Vasculotropin
18%
Zebra Fish
19%
Biochemistry, Genetics and Molecular Biology
Akt Signaling
5%
Angiogenesis
22%
Animal Experiment
7%
Apocynin
7%
Atrial Fibrillation
25%
Autophagy
16%
Bilayer Membrane
5%
Blood Flow
11%
Bone Morphogenetic Protein
5%
Brain Computer Interface
32%
Calmodulin
13%
Cardiac Muscle Cell
28%
Cathepsin B
16%
CD81
5%
CD98
16%
Cell Adhesion Molecule
21%
Cell Encapsulation
16%
Cell Function
21%
Cell Growth
8%
Cellular Secretion
8%
Chlamydia Pneumoniae
48%
Clinical Decision Making
8%
Clinical Trial Design
8%
Cohort Study
56%
Comorbidity
9%
Complement Factor B
16%
CREB
6%
Cyclic AMP Responsive Element Binding Protein
16%
Eicosanoid Receptor
13%
Endothelial Progenitor Cell
48%
Evoked Field
16%
Galectin-3
32%
Gene Expression
7%
Glucose Blood Level
16%
Glycogen Synthase Kinase 3
8%
GroEL
16%
Growth Factor
13%
Heart Ejection Fraction
8%
Heat Shock
16%
Heat Shock Protein
48%
Hemodialysis
16%
High-Density Lipoprotein
16%
Histone Deacetylase
8%
Histone Deacetylases Inhibitor
8%
Immunoglobulin Enhancer Binding Protein
21%
Interleukin 33
16%
Kinase
11%
Lactate Dehydrogenase
5%
LDL Receptor
19%
Lectin
21%
Leporidae
16%
Lipopolysaccharide
16%
Long Term Survival
8%
Low-Density Lipoprotein
39%
Macrophage
10%
MAPK Signaling
5%
Maturation
16%
Melatonin
16%
Messenger RNA
19%
Mitogen-Activated Protein Kinase
5%
Mortality Rate
16%
Mouse
25%
Mouse Model
11%
NAD(P)H Oxidase
10%
Necroptosis
16%
Neovascularization (Pathology)
16%
Nitric Oxide Synthase
19%
NLR Family Pyrin Domain containing 3
8%
NLRP3 Inflammasome
12%
Normal Human
19%
Periostin
20%
Phosphotransferase
11%
Pig
7%
Polymerase Chain Reaction
8%
Porphyromonas gingivalis
16%
Protein Kinase C
16%
Pulse Rate
16%
Rabbit Model
5%
Renin Angiotensin Aldosterone System
16%
RNA Interference
5%
RNA Sequencing
16%
RUNX2
16%
Secretion (Process)
16%
Secretome
5%
Signal Transduction
16%
Signaling Protein
5%
Small Interfering RNA
6%
SREBF1
6%
Steady State
48%
Thrombomodulin
16%
TLR4
40%
Transactivation
16%
Transcriptome
5%
TSG101
5%
Ubiquitin-Conjugating Enzyme
16%
Upregulation
6%
Vascular Endothelial Growth Factor
21%
Visual Evoked Potential
32%
Western Blot
9%
Wnt Signaling Pathway
16%